Fougera is continuing its mission to support AmeriCares. The pharmaceutical company, along with its parent company Nycomed US Inc, recently presented the international relief organization with a gift of medicines and other items.
The medicines, including topical steroids and topical antibiotics, were produced specifically for AmeriCares after the organization identified those most needed due to war, poverty, or natural disasters in countries throughout the world. The company's philanthropic program, Fougera Cares, has been helping the organization for 16 years.
"Fougera began making medicine in 1849, based on the belief that every person should have access to affordable, quality medication. This tradition remains at the core of our business model," said Paul McGarty, Nycomed chief executive officer. "Our 16-year relationship with AmeriCares has provided us an opportunity to help thousands of doctors, clinics, and hospitals in the United States and around the world with medicines that they would otherwise go without."
While many states across our nation are engaged in political battles over the recreational use of marijuana, researchers have been busy studying the medical benefits of cannabidiol.
News from the year's biggest meetings
Clinical features with downloadable PDFs